ClinicalTrials.gg
Not yet recruitingNCT07889063Updated Oct 22, 2026

Artificial Intelligence (AI)-Initiated Clinical Decision Support in Hospitalist Practice

An interventional study of AI Clinical Decision Support: Automated EHR Data Retrieval and AI Clinical Decision Support: Admission H&P Note in Clinical Decision Support, sponsored by Cedars-Sinai Medical Center. Not yet recruiting at 2 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Cedars-Sinai Medical Center · Not applicable, Interventional, and Health services research

Updated Oct 22, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will evaluate the feasibility of using artificial intelligence (AI)-generated clinical decision support during routine inpatient hospital medicine care. Participating hospitalist physicians may receive AI-generated recommendations for eligible hospitalized patients under their care. Eligible patient cases will be randomly assigned to one of three AI prompting strategies that differ in the clinical information provided to the AI system. After reviewing each recommendation, participating physicians will complete a brief survey assessing the clinical usefulness of the recommendation, how they interpreted it, and whether it was or will be incorporated into patient management.

The study will assess whether AI-generated recommendations can be successfully generated and delivered during routine clinical care and whether physicians complete the study surveys and adopt the recommendations. It will also provide preliminary information about physicians' perceptions of AI-generated recommendations across the three prompting strategies. The findings will be used to inform the design of a future larger randomized trial of AI-initiated clinical decision support.

Read the detailed description

This is a three-arm randomized feasibility trial evaluating AI-initiated clinical decision support in routine inpatient hospital medicine practice. Eligible patient cases cared for by participating hospitalist physicians will be randomized to one of three AI prompting strategies: automated electronic health record (EHR) data retrieval, automated EHR data retrieval with explicit inclusion of the admission history and physical (H\&P) note, or the admission H\&P note alone. OpenEvidence will generate a clinical decision support recommendation for each randomized case.

The recommendation will be delivered to the attending hospitalist, who will then complete a brief electronic survey assessing the clinical utility and interpretation of the recommendation and whether it was implemented or planned for implementation. The study will assess the feasibility of generating and delivering AI-initiated recommendations during routine clinical care, physician survey completion, timely survey completion, and recommendation adoption. Findings from this feasibility trial will inform the design of a future larger randomized trial.

02

Conditions studied

  • Clinical Decision Support

Keywords

  • Artificial Intelligence
  • Hospital Medicine
  • Hospitalists
  • Generative Artificial Intelligence
  • OpenEvidence
03

In context

Lead sponsor

Cedars-Sinai Medical Center is the lead sponsor of 455 studies on the registry; 108 are open to participants now.

Of its 65 completed or terminated interventional studies of FDA-regulated products, 49 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • Attending physician providing inpatient hospital medicine care at a participating Cedars-Sinai Health System site.
  • Expected to provide clinical care during the study period.
  • Willing and able to provide informed consent.

Exclusion criteria

Exclusion Criteria:

  • Declines to provide or withdraws informed consent.
  • Not actively providing attending-level inpatient care on a participating hospitalist service during the study period.
  • Unable to complete study procedures.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Arm D: Automated Electronic Health Record Data Retrieval Only

    Arm D (Data Retrieval Only): Eligible patient cases assigned to this arm will have the OpenEvidence recommendation generated using automated electronic health record (EHR) data retrieval without explicit inclusion of the admission history and physical (H\&P) note.

    Other: AI Clinical Decision Support: Automated EHR Data Retrieval

  • Experimental
    Arm DH: Automated EHR Data Retrieval + Admission H&P Note

    Arm DH (Data Retrieval + History and Physical): Eligible patient cases assigned to this arm will have the OpenEvidence recommendation generated using automated EHR data retrieval with explicit inclusion of the admission H\&P note.

    Other: AI Clinical Decision Support: Automated EHR Data Retrieval · Other: AI Clinical Decision Support: Admission H&P Note

  • Experimental
    Arm H: Admission H&P Note Only

    Arm H (History and Physical Only): Eligible patient cases assigned to this arm will have the OpenEvidence recommendation generated using the admission H\&P note only, without automated EHR data retrieval.

    Other: AI Clinical Decision Support: Admission H&P Note

Interventions

  • OtherAI Clinical Decision Support: Automated EHR Data Retrieval

    OpenEvidence generates an AI-based clinical decision support recommendation using automated retrieval of available EHR data.

  • OtherAI Clinical Decision Support: Admission H&P Note

    The admission H\&P note is explicitly provided to OpenEvidence as clinical context for generation of the AI-based clinical decision support recommendation.

06

What researchers measure

Primary outcomes

  1. Successful AI Recommendation Delivery Rate

    Proportion of randomized patient cases in which an AI-generated recommendation is successfully delivered to the attending hospitalist.

    Time frame: Within 24 hours of hospital admission

  2. Physician Survey Completion Rate

    Proportion of successfully delivered AI-generated recommendations for which the attending hospitalist completes the electronic physician survey.

    Time frame: Within 48 hours after AI recommendation delivery

  3. Timely Physician Survey Completion Rate

    Proportion of successfully delivered AI-generated recommendations for which the attending hospitalist completes the electronic physician research survey within 12 hours of recommendation delivery.

    Time frame: Within 12 hours of AI recommendation delivery

  4. Recommendation Adoption Rate

    Proportion of AI-generated recommendations that the attending hospitalist reports as implemented or planned for implementation. Responses will be recorded separately as implemented, planned but not yet implemented, or not adopted.

    Time frame: Within 48 hours after AI recommendation delivery

Secondary outcomes

  1. Physician-Perceived Clinical Utility

    Physician-perceived clinical utility of the AI-generated recommendation, assessed at the patient-case level using a single-item 0-10 numeric rating scale, with anchors at 0 ("Not at all useful"), 5 ("Moderately useful"), and 10 ("Extremely useful").

    Time frame: Within 48 hours after AI recommendation delivery

  2. Interpretation of AI-Generated Recommendations

    Physician interpretation of the AI-generated recommendation, assessed using six predefined response categories in the physician research survey.

    Time frame: Within 48 hours after AI recommendation delivery

  3. Physician-Reported Recommendation Adoption Status

    Physician-reported adoption of the AI-generated recommendation, categorized as implemented, planned but not yet implemented, or not adopted.

    Time frame: Within 48 hours after AI recommendation delivery

07

Study locations

2 sites
  • Cedars-Sinai Medical Center
    Los Angeles, California 90048, United States
  • Huntington Hospital
    Pasadena, California 91105, United States
08

References and documents

Individual participant data

Plan to share: No — Individual participant data are not planned for public sharing as part of this feasibility study.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07889063
Responsible party
Josh Pevnick (Associate Professor of Medicine, Cedars-Sinai Medical Center) — Principal investigator
First posted
Oct 22, 2026
Start date
Oct 2026 (estimated)
Primary completion
Oct 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Oct 22, 2026

Study contacts

Joshua M Pevnick, MD
Contact
Joshua.Pevnick@csmc.edu
310-423-4683
Joshua M Pevnick, MD
principal investigator · Cedars-Sinai Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion